Vaylen vs CoreAgeRx: Compounded GLP-1 Pricing and Options

Vaylen vs CoreAgeRx answers the basic question of price structure and product format quickly: Vaylen emphasizes prepaid 12-month plans with compounded semaglutide from $83.25/mo while CoreAgeRx highlights flat month to month pricing with semaglutide at $79/mo and tirzepatide at $129/mo. Early verdict: choose Vaylen if you want the lowest effective rate on a prepaid 12-month compounded plan and accept prepaid billing; choose CoreAgeRx if you prefer flat monthly billing that the provider advertises as the same price every month.

See Vaylen prepaid GLP-1 plans

How they charge and what you pay

Both providers present cash-pay GLP-1 programs, but their billing approaches differ. Vaylen publishes annualized rates billed upfront: semaglutide injections from $83.25/mo on a 12-month plan (billed as $999), oral semaglutide $99/mo on the 12-month plan, and tirzepatide $149/mo on the 12-month plan. Vaylen also lists month-to-month alternatives, for example $224/mo for semaglutide. CoreAgeRx promotes flat monthly pricing, listing semaglutide at $79/mo and tirzepatide at $129/mo and stating no membership fee and no price hikes. The comparison depends on whether you value a prepaid discount or predictable month-to-month billing.

Billing trade offs

Vaylen requires prepaying a full 12 months to access its headline rates and states you pay before clinician review, with a published full refund if the clinician declines. CoreAgeRx frames its offer as the same price every month and emphasizes no memberships and no surprise increases. The providers state that treatment is available only when a licensed clinician determines it is medically appropriate.

View CoreAgeRx monthly pricing

Product formats and molecules compared

Vaylen lists three formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide injections, all offered as compounded medications. CoreAgeRx lists semaglutide up to 1.0 mg and tirzepatide up to 7.5 mg with flat monthly pricing. Vaylen highlights a needle-free oral tablet option; CoreAgeRx does not publish an oral format in the captured evidence.

Regulatory and product notes

Both indicate that compounded medications are not FDA approved finished products and are not reviewed by the FDA for safety, effectiveness or quality when compounded products are offered. Vaylen repeats this regulatory note in its disclosures and lists the compounded status in multiple places. CoreAgeRx captures a similar regulatory caution in its evidence.

Distinctive differences at a glance

Criteria	Vaylen	CoreAgeRx
Headline pricing	Semaglutide from $83.25/mo on 12-month plan; $224/mo monthly	Semaglutide $79/mo; Tirzepatide $129/mo; flat monthly pricing
Billing model	Prepaid 12-month plans billed upfront; month-to-month available	Flat monthly pricing; no membership fee stated
Formats offered	Injectable semaglutide, oral semaglutide tablets, tirzepatide injectables	Semaglutide and tirzepatide doses advertised; oral format not captured
Refunds and clinician review	Pay first, clinician review within 24 hours; full refund if clinician declines	Captured evidence did not publish a full refund policy
Shipping and turnaround	Free discreet shipping in 1 to 3 business days	Shipping speed not verified on captured landing page

Compare Vaylen formats and shipping

Clinical access and eligibility

Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate. Vaylen describes telehealth consultations included, by live video or asynchronous review, and a clinician review within 24 hours. CoreAgeRx notes a 3-minute online visit in its captured content but other verification details were not published on the captured landing page.

Which differences matter most

Three distinctive supported differences separate Vaylen and CoreAgeRx: price structure and prepayment, the presence of an oral semaglutide tablet on Vaylen, and the explicit refund-if-declined policy that Vaylen publishes for prepaid cycles. Shipping speed and clinician turnaround are called out for Vaylen in the captured evidence; CoreAgeRx emphasizes no price increases and flat monthly billing but captured details on shipping and renewal terms were not published or could not be verified on the captured landing page.

Lock in CoreAgeRx monthly pricing

Conclusion: Vaylen vs CoreAgeRx

In summary, Vaylen vs CoreAgeRx comes down to prepaid discount versus flat monthly predictability and whether you want an oral tablet option. Vaylen offers lower headline monthly rates on a prepaid 12-month plan, multiple formats including an oral semaglutide tablet, free discreet shipping in 1 to 3 business days, and a published full refund if a clinician declines. CoreAgeRx advertises flat monthly pricing with no membership fee and lists semaglutide at $79/mo and tirzepatide at $129/mo, with captured evidence emphasizing consistent billed price each month.

Choose Vaylen if you want the lowest effective monthly rate on a prepaid 12-month compounded plan, prefer multiple formats including an oral tablet, and accept paying before clinician review with Vaylen’s stated refund-if-declined policy.

Choose CoreAgeRx if you prefer flat monthly billing marketed as the same price every month and want to avoid prepaying a year based on the captured evidence about pricing and membership terms.

Start with Vaylen plans